Vascular disruption has been implicated in coronavirus disease 2019 (COVID-19)
pathogenesis and may predispose to the neurological sequelae associated with long …

The presence of symptoms after an acute SARS-CoV-2 infection (long-COVID) has become
a worldwide healthcare emergency but remains underestimated and undertreated due to a …

Long COVID (LC) is a condition in which patients do not fully recover from the initial SARS-
CoV-2 infection but rather have persistent or new symptoms for months to years following …

The COVID-19 pandemic caused by SARS-CoV-2 has triggered a consequential public
health crisis of post-acute sequelae of COVID-19 (PASC), sometimes referred to as long …

Background Studies have established the short-term efficacy of nirmatrelvir–ritonavir in
managing COVID-19, yet its effect on post-COVID-19 condition, especially in patients …

Background Growing evidence suggests that symptoms associated with post-COVID-19
condition (also known as long COVID) can affect multiple organs and systems in the human …

The reduced pathogenicity of the omicron BA. 1 sub-lineage compared to earlier variants is
well described, although whether such attenuation is retained for later variants like BA. 5 …

Long COVID research risks losing momentum – we need a moonshot Skip to main content
Thank you for visiting nature.com. You are using a browser version with limited support for …

Importance There is an urgent need to identify treatments for postacute sequelae of SARS-
CoV-2 infection (PASC). Objective To assess the efficacy of a 15-day course of nirmatrelvir …

OBJECTIVE: COVID-19 patients experience, in 10-20% of the cases, a prolonged long-
COVID syndrome, defined as the persistence of symptoms for at least two months after the …